Wells Fargo’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$129K Sell
35,299
-4,919
-12% -$18K ﹤0.01% 4644
2025
Q1
$174K Sell
40,218
-1,253
-3% -$5.41K ﹤0.01% 4361
2024
Q4
$133K Buy
41,471
+9,464
+30% +$30.3K ﹤0.01% 4554
2024
Q3
$91.5K Buy
32,007
+1,185
+4% +$3.39K ﹤0.01% 4674
2024
Q2
$86.3K Buy
30,822
+6,411
+26% +$18K ﹤0.01% 4652
2024
Q1
$69.3K Buy
24,411
+3,141
+15% +$8.92K ﹤0.01% 4729
2023
Q4
$87K Buy
21,270
+4,262
+25% +$17.4K ﹤0.01% 4585
2023
Q3
$54.1K Sell
17,008
-10,059
-37% -$32K ﹤0.01% 4793
2023
Q2
$89.9K Buy
27,067
+12,456
+85% +$41.4K ﹤0.01% 4846
2023
Q1
$31.1K Buy
14,611
+10,686
+272% +$22.8K ﹤0.01% 5125
2022
Q4
$10.6K Sell
3,925
-2,196
-36% -$5.91K ﹤0.01% 5209
2022
Q3
$20K Sell
6,121
-4,835
-44% -$15.8K ﹤0.01% 5075
2022
Q2
$54K Sell
10,956
-201,056
-95% -$991K ﹤0.01% 4717
2022
Q1
$1.62M Buy
212,012
+4,774
+2% +$36.4K ﹤0.01% 3291
2021
Q4
$1.92M Sell
207,238
-284,775
-58% -$2.63M ﹤0.01% 3331
2021
Q3
$7.01M Buy
492,013
+271,615
+123% +$3.87M ﹤0.01% 2429
2021
Q2
$3.66M Sell
220,398
-9,874
-4% -$164K ﹤0.01% 3016
2021
Q1
$4.2M Buy
230,272
+167,072
+264% +$3.04M ﹤0.01% 2860
2020
Q4
$476K Buy
63,200
+33,230
+111% +$250K ﹤0.01% 4472
2020
Q3
$115K Buy
29,970
+9,566
+47% +$36.7K ﹤0.01% 5012
2020
Q2
$78K Buy
20,404
+10,036
+97% +$38.4K ﹤0.01% 5113
2020
Q1
$33K Sell
10,368
-7,322
-41% -$23.3K ﹤0.01% 5233
2019
Q4
$85K Buy
17,690
+12,288
+227% +$59K ﹤0.01% 5138
2019
Q3
$36K Buy
5,402
+5,323
+6,738% +$35.5K ﹤0.01% 5346
2019
Q2
$1K Buy
+79
New +$1K ﹤0.01% 5793